Of 53 pre-treatment tumor specimens, molecular testing was performed as follows: conventional p16 (DAB) scores, n = 35; p16 AQUA, n = 46; HPV16 CISH, n = 42; HPV subtyping, n = 36. The gene discussed is CDKN2A; the disease is neoplasm.